Literature DB >> 23728252

FX and host defense evasion tactics by adenovirus.

Andrew H Baker1, Stuart A Nicklin, Dmitry M Shayakhmetov.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23728252      PMCID： PMC3677301          DOI： 10.1038/mt.2013.100

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  30 in total

1.  Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors.

Authors:  Raul Alba; Angela C Bradshaw; Lynda Coughlan; Laura Denby; Robert A McDonald; Simon N Waddington; Suzanne M K Buckley; Jenny A Greig; Alan L Parker; Ashley M Miller; Hongjie Wang; Andre Lieber; Nico van Rooijen; John H McVey; Stuart A Nicklin; Andrew H Baker
Journal:  Blood       Date:  2010-07-07       Impact factor: 22.113

Review 2.  The influence of adenovirus fiber structure and function on vector development for gene therapy.

Authors:  Stuart A Nicklin; Eugene Wu; Glen R Nemerow; Andrew H Baker
Journal:  Mol Ther       Date:  2005-09       Impact factor: 11.454

3.  Substitution of hexon hypervariable region 5 of adenovirus serotype 5 abrogates blood factor binding and limits gene transfer to liver.

Authors:  Frédéric Vigant; Delphyne Descamps; Betsy Jullienne; Stéphanie Esselin; Elisabeth Connault; Paule Opolon; Thierry Tordjmann; Emmanuelle Vigne; Michel Perricaudet; Karim Benihoud
Journal:  Mol Ther       Date:  2008-06-17       Impact factor: 11.454

4.  HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses.

Authors:  R P Tomko; R Xu; L Philipson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

5.  Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity.

Authors:  Dmitry M Shayakhmetov; Anuj Gaggar; Shaoheng Ni; Zong-Yi Li; André Lieber
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

6.  Adenovirus induction of IRF3 occurs through a binary trigger targeting Jun N-terminal kinase and TBK1 kinase cascades and type I interferon autocrine signaling.

Authors:  Marcelo Nociari; Oksana Ocheretina; Mary Murphy; Erik Falck-Pedersen
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

7.  Coagulation factor X mediates adenovirus type 5 liver gene transfer in non-human primates (Microcebus murinus).

Authors:  R Alba; A C Bradshaw; N Mestre-Francés; J-M Verdier; D Henaff; A H Baker
Journal:  Gene Ther       Date:  2011-06-16       Impact factor: 5.250

8.  Biodistribution and inflammatory profiles of novel penton and hexon double-mutant serotype 5 adenoviruses.

Authors:  Angela C Bradshaw; Lynda Coughlan; Ashley M Miller; Raul Alba; Nico van Rooijen; Stuart A Nicklin; Andrew H Baker
Journal:  J Control Release       Date:  2012-05-22       Impact factor: 9.776

9.  Tropism-modification strategies for targeted gene delivery using adenoviral vectors.

Authors:  Lynda Coughlan; Raul Alba; Alan L Parker; Angela C Bradshaw; Iain A McNeish; Stuart A Nicklin; Andrew H Baker
Journal:  Viruses       Date:  2010-10-13       Impact factor: 5.818

10.  Targeting of adenovirus serotype 5 (Ad5) and 5/47 pseudotyped vectors in vivo: fundamental involvement of coagulation factors and redundancy of CAR binding by Ad5.

Authors:  Simon N Waddington; Alan L Parker; Menzo Havenga; Stuart A Nicklin; Suzanne M K Buckley; John H McVey; Andrew H Baker
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103
View more
  5 in total

1.  The superior role of coagulation factor FX over FVII in adenoviral-mediated innate immune induction of the hepatocyte: an in vitro experiment.

Authors:  Saeed Firoozi Ghahestani; Alireza Shiri; Afagh Moattari; Jamal Sarvari; Ali Moahammad Tamaddon; Seyed Younes Hossein
Journal:  Clin Exp Hepatol       Date:  2020-09-30

2.  Human full-length coagulation factor X and a GLA domain-derived 40-mer polypeptide bind to different regions of the adenovirus serotype 5 hexon capsomer.

Authors:  Sudir Sumarheni; Saw See Hong; Véronique Josserand; Jean-Luc Coll; Pierre Boulanger; Guy Schoehn; Pascal Fender
Journal:  Hum Gene Ther       Date:  2014-03-25       Impact factor: 5.695

3.  Hexon hypervariable region-modified adenovirus type 5 (Ad5) vectors display reduced hepatotoxicity but induce T lymphocyte phenotypes similar to Ad5 vectors.

Authors:  Jeffrey E Teigler; Pablo Penaloza-MacMaster; Rebecca Obeng; Nicholas M Provine; Rafael A Larocca; Erica N Borducchi; Dan H Barouch
Journal:  Clin Vaccine Immunol       Date:  2014-06-18

Review 4.  Immunotherapy by mesenchymal stromal cell delivery of oncolytic viruses for treating metastatic tumors.

Authors:  A-Rum Yoon; Cosette Rivera-Cruz; Jeffrey M Gimble; Chae-Ok Yun; Marxa L Figueiredo
Journal:  Mol Ther Oncolytics       Date:  2022-03-19       Impact factor: 7.200

5.  Traceless bioresponsive shielding of adenovirus hexon with HPMA copolymers maintains transduction capacity in vitro and in vivo.

Authors:  Jan-Michael Prill; Vladimír Subr; Noemi Pasquarelli; Tatjana Engler; Andrea Hoffmeister; Stefan Kochanek; Karel Ulbrich; Florian Kreppel
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.